Powered by

Federation Bio goes live with $50M to pursue microbial treatments

Oct 06, 2020 - FierceBiotech

Several companies are exploring microbiome treatments for various ailments, ranging from Parkinson's disease and multiple sclerosis to more usual suspects like gastrointestinal infections. One company, Federation Bio, thinks its approach can top the rest, and its new CEO—not to mention investors—agree.

The company launches with $50 million and science so compellingit convinced Emily Drabant Conley, formerly 23andMe's vice president of business development, to leave the genomics company...